Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Leeza Osipenko being referenced
Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Leeza Osipenko | 112 | 21 | 20 | 43 | 42 | 20 | 293 | |
| Enrico Costa | 87 | 14 | 19 | 29 | 47 | 26 | 268 | |
| Philippe Van Wilder | 124 | 14 | 25 | 14 | 27 | 21 | 318 | |
| Wendy Vogel | 33 | 61 | 10 | 22 | 34 | 17 | 272 | |
| Shanda Finnigan | 66 | 88 | 32 | 57 | 36 | 18 | 284 | |
| Tamás Zelei | 127 | 17 | 69 | 13 | 14 | 26 | 317 | |
| Iyar Mazar | 44 | 22 | 12 | 32 | 13 | 19 | 293 | |
| Ashwini Shewade | 34 | 17 | 3 | 44 | 55 | 25 | 251 | |
| Eoin McGrath | 36 | 85 | 55 | 158 | 47 | 24 | 311 | |
| Frank Liu | 27 | 21 | 6 | 37 | 56 | 26 | 278 | |
| Alice Bessey | 18 | 70 | 13 | 21 | 35 | 12 | 302 |
All Works
Loading papers...